Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)

Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27) The purpose of this Notice of Amendment is to notify about the additions of: - Strain Russian BCG-I to the "including" column of the |Bacillus Calmette-Guérin (BCG)" entry on the Prescription Drug List for human and veterinary use, - Bedinvetmab to the PDL for veterinary use, and - Binimetinib, Brillant Blue G, encorafenib, eptinezumab, mecasermin, onasemnogene abeparvovec, ponesimod, ranolazine, triheptanoin and zanubrutinib to the PDL for human and veterinary use. 2023-09-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetynotice of amendmentPrescription Drug ListPDLStrain Russian BCG-IBacillus Calmette-Guérinhuman-and-veterinary useBedinvetmabBinimetinibBrillant Blue Gencorafenibeptinezumabmecaserminonasemnogene abeparvovecponesimodranolazinetriheptanoinzanubrutinib Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2021-05-27.html Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/liste-drogues-ordonnance/avis-concernant-modifications/additions-multiples-2021-05-27.html

The purpose of this Notice of Amendment is to notify about the additions of: - Strain Russian BCG-I to the "including" column of the |Bacillus Calmette-Guérin (BCG)" entry on the Prescription Drug List for human and veterinary use, - Bedinvetmab to the PDL for veterinary use, and - Binimetinib, Brillant Blue G, encorafenib, eptinezumab, mecasermin, onasemnogene abeparvovec, ponesimod, ranolazine, triheptanoin and zanubrutinib to the PDL for human and veterinary use.

Data and Resources

Similar records